The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Study of INCB086550 in Select Solid Tumors
Official Title: A Phase 2 Study of INCB086550 (Oral PD-L1 Inhibitor) in Participants Who Are Immune Checkpoint Inhibitor-Naïve With Selected Solid Tumors
Study ID: NCT04629339
Brief Summary: An open-label, nonrandomized study to evaluate the efficacy and safety of INCB086550, a first-in-class oral inhibitor of PD-L1, as initial immune checkpoint inhibitor therapy in participants with select solid tumors
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Complex Oncology Center - Burgas Eood, Burgas, , Bulgaria
Multiprofile Hospital For Active Treatment "Dr. Tota Venkova" Jsc, Gabrovo, , Bulgaria
Complex Onclogy Center Plovdiv Eood, Plovdiv, , Bulgaria
Shatod Dr. Marko - Varna Ltd, Varna, , Bulgaria
Semmelweis Egyetem, Budapest, , Hungary
Complex Oncology Center - Burgas Eood, Farkasgyepu, , Hungary
Bacs Kiskun Megyei Oktatokorhaz, Kecskemet, , Hungary
The Catholic University of Korea St. Vincent'S Hospital, Gyeonggi-do, , Korea, Republic of
Korea University Anam Hospital, Seoul, , Korea, Republic of
Severance Hospital Yonsei University Health System, Seoul, , Korea, Republic of
Asan Medical Center, Seoul, , Korea, Republic of
Ajou University Hospital, Suwon, , Korea, Republic of
Chang Gung Memorial Hospital Linkou, Taoyuan City, , Taiwan
Multifield Clinical Hospital No 4, Dnipro, , Ukraine
Ci of Healthcare Regional Clinical Specialized Dispensary of the Radiation Protection, Kharkiv, , Ukraine
Mi Kryviy Rih Center of Dnipropetrovsk Regional Council, Kryvyi Rih, , Ukraine
Volyn Regional Oncological Dispensary, Lutsk, , Ukraine
Rmi Sumy Regional Clinical Oncology Dispensary, Sumy, , Ukraine
Cne Ccch of Uzh Cc Oncological Center, Uzhgorod, , Ukraine
Medical Clinic Innovacia Llc, Vyshhorod, , Ukraine